Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBS
Since 2010, global R&D spending on CRO and tech vendor services has nearly doubled. But instead of seeing faster trials, the industry measured longer study timelines.
Investigators and their staff are telling us that next-gen tools and third-party vendors now add too much complexity to their lives. The result: they’re turning down trials.
in spending for clinical technology and services from 2010-2020
in Phase 3 study initiation times since 2015
report insufficient bandwidth to run trials
Many sponsors, CROs, and tech vendors have individual initiatives to improve the site experience across their own trials and products. But investigators run trials for multiple sponsors, and sponsors use products from many different vendors.
Unless these individual efforts get connected at the site level, they won’t reduce complexity or deliver a positive impact on the industry.
A single home for sites where all industry stakeholders contribute
One Home for Sites is the only product that serves as a neutral aggregator, connector, and communicator of the key systems and tasks a site needs to perform across all the clinical trials it is conducting.
When sponsors, CROs, and tech vendors tap into the power of One Home, they amplify the benefits to sites and their own organizations.
 |
Single sign on |
 |
Task management |
 |
Site engagement and chat |
For nearly 60 years, IQVIA has been developing successful products built on industry collaborations that move healthcare forward.
With a history of site-focused products from our DrugDev heritage, IQVIA is the ONLY provider with everything needed to start this movement:
Join us as we bring together sites, sponsors, and tech partners to build One Home for Sites.
Access this IDC Research Note covering IQVIA One Home for Sites and its potential to address the multisystem-access fatigue that sites are experiencing.
Explore IDC’s point of view that the One Home product launch underscores IQVIA's leadership in unifying the industry to transform clinical trials.
Be a part of the only platform that’s bringing the industry together to help sites survive and thrive, along with their patients.
See how One Home for Sites aggregates and communicates the key tasks a site needs to perform across all its systems and trials.
Be a part of the only platform that’s bringing the industry together to help sites survive and thrive, along with their patients.
Communication, collaboration and transparency between sites and sponsors mean trials start up and close out faster.
Increase transparency, improve communications and reduce administrative burden for all clinical trial stakeholders.
Ease the burden on your sites and make it easier and more appealing for patients to enroll and remain engaged.
